{
  "abstract": "Lung cancer (LC) remains the deadliest cancer in the world and LC screening programmes continue to expand across healthcare systems to improve outcomes by earlier detection.1 Following results from screening trials, multiple countries have implemented their versions of LC screening programmes or have expanded their screening eligibility criteria.2–5",
  "authors": [
    {
      "affiliations": [
        "Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"
      ],
      "name": "Ramin Rezaeianzadeh"
    },
    {
      "affiliations": [
        "Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"
      ],
      "name": "Mohsen Sadatsafavi"
    }
  ],
  "title": "Getting more than early detection from lung cancer screening",
  "uid": "3975fdf8-7d20-542b-ae24-a3d44fa23d98"
}